1 00:00:00,000 --> 00:00:02,319 Hi, everyone. This is Erica Spicer Mason with 2 00:00:02,319 --> 00:00:04,480 Becker's Healthcare. Thank you so much for tuning 3 00:00:04,480 --> 00:00:06,660 into the Becker's Healthcare podcast series. 4 00:00:07,040 --> 00:00:08,880 So today we're going to talk about managing 5 00:00:08,880 --> 00:00:11,139 GLP-one costs and patient outcomes. 6 00:00:11,439 --> 00:00:13,919 And joining me for this conversation is Jennifer 7 00:00:13,919 --> 00:00:16,785 Jones, the director of clinical solutions at Noom 8 00:00:16,785 --> 00:00:19,505 Health. Jennifer, welcome. Thank you so much for 9 00:00:19,505 --> 00:00:21,425 being with us on-site at the annual meeting 10 00:00:21,425 --> 00:00:23,984 today. Absolutely. Happy to be here. So before 11 00:00:23,984 --> 00:00:25,904 we get into our conversation, and I'm really 12 00:00:25,904 --> 00:00:27,904 excited about this one. GLP ones are so 13 00:00:27,904 --> 00:00:30,600 top of mind for many. Mhmm. But before 14 00:00:30,600 --> 00:00:31,800 we do that, would you like to share 15 00:00:31,800 --> 00:00:33,479 just a little bit more about yourself, your 16 00:00:33,479 --> 00:00:36,039 background, your work in healthcare? Yeah, absolutely. So 17 00:00:36,039 --> 00:00:37,979 I actually started as a registered dietitian. 18 00:00:38,439 --> 00:00:39,260 When I graduated 19 00:00:39,960 --> 00:00:41,880 and completed my internship, I actually worked in 20 00:00:41,880 --> 00:00:45,135 a couple different healthcare settings and quickly realized 21 00:00:45,135 --> 00:00:46,594 that was not the place for 22 00:00:46,975 --> 00:00:49,054 me. While I loved patient care, I did 23 00:00:49,054 --> 00:00:50,734 not love kind of I hate to call 24 00:00:50,734 --> 00:00:53,534 it like the stiffness of clinical work, but 25 00:00:53,534 --> 00:00:55,695 wanted to do just just more with that, 26 00:00:55,935 --> 00:00:58,390 have a bigger impact truly. So I kind 27 00:00:58,390 --> 00:01:00,170 of bounced around doing some different, 28 00:01:00,630 --> 00:01:02,170 employer health and, 29 00:01:02,870 --> 00:01:03,770 data analytics 30 00:01:04,390 --> 00:01:07,189 before coming into Noom, which really has found, 31 00:01:07,189 --> 00:01:09,130 I'd say, like the sweet spot for me, 32 00:01:09,270 --> 00:01:12,310 weight management and overweight treatment has always been 33 00:01:12,310 --> 00:01:13,450 a passion of mine. 34 00:01:13,885 --> 00:01:16,765 So at Noom, it's been really helpful to 35 00:01:16,765 --> 00:01:19,244 see kind of the the biology and the 36 00:01:19,244 --> 00:01:22,204 medication and the the weight management components all 37 00:01:22,204 --> 00:01:22,944 come together 38 00:01:23,405 --> 00:01:26,045 as we think about helping people lose sustainable 39 00:01:26,045 --> 00:01:28,909 weight and then overlaying that with medications, 40 00:01:29,450 --> 00:01:32,009 when applicable as well. Yeah. Oh, well, it's 41 00:01:32,009 --> 00:01:33,689 great to learn more about you, Jennifer. Thank 42 00:01:33,689 --> 00:01:35,209 you for sharing that. And it sounds like 43 00:01:35,209 --> 00:01:36,729 at Noom, to your point, you're really at 44 00:01:36,729 --> 00:01:38,890 the intersection of so many issues that are 45 00:01:38,890 --> 00:01:40,170 happening in health care right now when it 46 00:01:40,170 --> 00:01:41,149 comes to weight management, 47 00:01:41,594 --> 00:01:44,174 the costs associated with it, and health outcomes. 48 00:01:44,234 --> 00:01:44,734 So 49 00:01:45,115 --> 00:01:47,515 excited to get into that. And I wanted 50 00:01:47,515 --> 00:01:50,715 to also just start broadly by acknowledging something 51 00:01:50,715 --> 00:01:52,635 many of our listeners probably are well aware 52 00:01:52,635 --> 00:01:55,115 of, which is that GLP one consumer demand 53 00:01:55,115 --> 00:01:57,769 and the costs are soaring. Mhmm. So as 54 00:01:57,769 --> 00:02:00,649 this treatment gains traction, what are the unique 55 00:02:00,649 --> 00:02:03,209 challenges and opportunities that payers are facing right 56 00:02:03,209 --> 00:02:04,649 now? Could you just give us, like, a 57 00:02:04,649 --> 00:02:06,649 high level view of where we're at? Yeah. 58 00:02:06,649 --> 00:02:09,534 I think the biggest challenge is a lot 59 00:02:09,534 --> 00:02:11,534 of payers just still don't know what to 60 00:02:11,534 --> 00:02:12,894 do about it. Should they cover it or 61 00:02:12,894 --> 00:02:14,735 should they not cover it? If they cover 62 00:02:14,735 --> 00:02:17,454 it, should we have specific limitations on who 63 00:02:17,454 --> 00:02:19,294 can have access to that? Should it just 64 00:02:19,294 --> 00:02:20,354 be certain diagnoses? 65 00:02:20,974 --> 00:02:22,974 And then it becomes how long should we 66 00:02:22,974 --> 00:02:24,914 cover the medication as well? So 67 00:02:25,729 --> 00:02:28,049 it's always from this frame of mind of 68 00:02:28,049 --> 00:02:29,430 thinking about utilization 69 00:02:29,889 --> 00:02:32,449 and then paying for this and the cost 70 00:02:32,449 --> 00:02:33,750 associated with it. 71 00:02:34,209 --> 00:02:36,530 And what I think we really need to 72 00:02:36,530 --> 00:02:38,370 turn into and focus on is also kind 73 00:02:38,370 --> 00:02:40,585 of that individual that is on the medication 74 00:02:40,585 --> 00:02:42,985 and thinking about this overall experience for the 75 00:02:42,985 --> 00:02:43,485 member 76 00:02:43,865 --> 00:02:45,324 and how we can best 77 00:02:45,705 --> 00:02:48,104 align them with the best protocols, the best 78 00:02:48,104 --> 00:02:50,585 medication, but also behavior change to make it 79 00:02:50,585 --> 00:02:52,525 a more impactful type of 80 00:02:52,879 --> 00:02:54,900 prescription for them, essentially. So 81 00:02:55,199 --> 00:02:57,280 from a payer perspective, again, I think there's 82 00:02:57,280 --> 00:03:00,659 just so much unknown because we continue to 83 00:03:00,719 --> 00:03:03,539 utilize the medications, which can be incredibly impactful. 84 00:03:04,159 --> 00:03:05,680 But we've all we have done is see 85 00:03:05,680 --> 00:03:08,055 the cost rise as far as overall healthcare 86 00:03:08,055 --> 00:03:08,875 costs. So 87 00:03:09,175 --> 00:03:10,615 we need to be able to find a 88 00:03:10,615 --> 00:03:12,935 solution that can intersect the two so we 89 00:03:12,935 --> 00:03:13,915 can see outcomes 90 00:03:14,294 --> 00:03:17,655 that will effectively reduce healthcare costs. And that's 91 00:03:17,655 --> 00:03:19,594 kind of that missing piece that, 92 00:03:20,000 --> 00:03:22,319 payers and providers, I think, are really struggling 93 00:03:22,319 --> 00:03:24,900 with right now. Yeah. Absolutely. And, 94 00:03:25,359 --> 00:03:27,439 you know, you touched on this idea of 95 00:03:27,439 --> 00:03:27,939 payers 96 00:03:28,319 --> 00:03:29,840 kind of having to decide if it's something 97 00:03:29,840 --> 00:03:31,599 they wanna cover, if they do, for how 98 00:03:31,599 --> 00:03:33,519 long. So really touching on that tension of 99 00:03:33,519 --> 00:03:34,019 sustainability 100 00:03:34,319 --> 00:03:35,539 and also access. 101 00:03:36,425 --> 00:03:37,164 Any other 102 00:03:37,465 --> 00:03:39,224 thoughts that come to mind on strategies that 103 00:03:39,224 --> 00:03:41,465 payers should really consider to to strike that 104 00:03:41,465 --> 00:03:42,525 balance right now? 105 00:03:42,905 --> 00:03:45,145 We have always focused on behavior change and, 106 00:03:45,145 --> 00:03:47,145 like, the psychology meeting. That's what Noom was 107 00:03:47,145 --> 00:03:49,199 founded upon, and that's where we have found 108 00:03:49,199 --> 00:03:51,840 our success in particular in the consumer market 109 00:03:51,840 --> 00:03:54,319 even before GLP ones really became a hot 110 00:03:54,319 --> 00:03:54,819 topic. 111 00:03:55,199 --> 00:03:57,680 So where we find success and, again, where 112 00:03:57,680 --> 00:04:00,500 we really push the market to understand is 113 00:04:00,719 --> 00:04:02,419 an individual on these medications 114 00:04:02,719 --> 00:04:03,699 will have success. 115 00:04:04,245 --> 00:04:04,745 Sure. 116 00:04:05,044 --> 00:04:07,205 But will it be long term success? If 117 00:04:07,205 --> 00:04:08,724 they come off the medication, are they gonna 118 00:04:08,724 --> 00:04:10,405 be able to maintain that weight loss? So 119 00:04:10,405 --> 00:04:12,084 we need to be able to find, again, 120 00:04:12,084 --> 00:04:14,724 that missing factor, which in our eyes is 121 00:04:14,724 --> 00:04:16,425 that behavior change. So 122 00:04:16,769 --> 00:04:19,170 if you can get someone to be able 123 00:04:19,170 --> 00:04:21,189 to think about the way they eat differently 124 00:04:21,649 --> 00:04:23,889 and be able to know the importance of 125 00:04:23,889 --> 00:04:26,230 these lifestyle factors that they're choosing 126 00:04:26,689 --> 00:04:28,689 and how that can not only help you 127 00:04:28,689 --> 00:04:30,149 lose more weight with medication, 128 00:04:30,574 --> 00:04:32,415 but ensure that maybe you can come off 129 00:04:32,415 --> 00:04:34,334 of the medication and then ensure that you 130 00:04:34,334 --> 00:04:36,675 can maintain that weight loss after the medication. 131 00:04:37,535 --> 00:04:39,615 That's really that sweet spot that I think 132 00:04:39,615 --> 00:04:41,875 we're missing right now in the market is 133 00:04:42,415 --> 00:04:45,294 how can we also apply lifestyle to the 134 00:04:45,294 --> 00:04:45,600 effects 135 00:04:47,199 --> 00:04:49,540 medications? Yeah. That that's such a helpful perspective. 136 00:04:49,600 --> 00:04:50,100 And 137 00:04:50,480 --> 00:04:52,800 just to share something personal quickly, I'm a 138 00:04:52,800 --> 00:04:54,959 former health educator. So what you're saying is 139 00:04:54,959 --> 00:04:56,639 completely speaking to what I know to be 140 00:04:56,639 --> 00:04:58,480 true, which is behavior change is probably one 141 00:04:58,480 --> 00:05:00,454 of probably one of the most difficult things 142 00:05:00,774 --> 00:05:03,095 Absolutely. To pull off, but it's so important 143 00:05:03,095 --> 00:05:05,035 for something like this to see sustainability. 144 00:05:06,294 --> 00:05:08,454 So keeping that in mind, what are some 145 00:05:08,454 --> 00:05:10,074 specific examples of, 146 00:05:10,535 --> 00:05:11,189 you know, 147 00:05:11,509 --> 00:05:14,629 support or other approaches that payers can take 148 00:05:14,629 --> 00:05:16,709 in order to really achieve that? I know 149 00:05:16,709 --> 00:05:18,709 you mentioned education as a piece of it. 150 00:05:19,029 --> 00:05:20,870 Any other examples come to mind? I think 151 00:05:20,870 --> 00:05:22,709 the support is a a key piece too. 152 00:05:22,709 --> 00:05:23,689 I think oftentimes, 153 00:05:24,625 --> 00:05:26,644 we treat obesity just as 154 00:05:27,024 --> 00:05:29,904 obesity, and there's certainly much more recognition that 155 00:05:29,904 --> 00:05:32,064 it is a chronic condition now. And with 156 00:05:32,064 --> 00:05:33,904 a chronic condition, there needs to be that 157 00:05:33,904 --> 00:05:34,964 holistic support. 158 00:05:35,504 --> 00:05:37,125 So you have the medication, 159 00:05:37,500 --> 00:05:40,139 we have the behavior change. Now a missing 160 00:05:40,139 --> 00:05:41,680 piece there is that community 161 00:05:41,980 --> 00:05:43,980 type of support, the mental health type of 162 00:05:43,980 --> 00:05:45,899 support that goes along with treating any other 163 00:05:45,899 --> 00:05:46,720 chronic condition. 164 00:05:47,100 --> 00:05:49,660 So understanding that people need connections and they 165 00:05:49,660 --> 00:05:51,785 need to be able to have someone that 166 00:05:51,785 --> 00:05:53,165 they can go to for support 167 00:05:53,625 --> 00:05:55,544 when they're hitting their highs, when they're hitting 168 00:05:55,544 --> 00:05:57,404 their lows, when they they have questions, 169 00:05:57,865 --> 00:06:00,504 as well as other individuals that are going 170 00:06:00,504 --> 00:06:02,264 through the same types of struggles and the 171 00:06:02,264 --> 00:06:04,444 same type of path with them as well. 172 00:06:04,740 --> 00:06:07,160 So being able to, from a payer perspective, 173 00:06:07,939 --> 00:06:09,560 have those types of communities, 174 00:06:10,180 --> 00:06:13,139 and connections that you can connect individuals with 175 00:06:13,139 --> 00:06:14,500 that are going through the journey. I think 176 00:06:14,500 --> 00:06:16,579 that oftentimes, again, is another piece that 177 00:06:17,464 --> 00:06:19,225 and as we think about the treatment of 178 00:06:19,225 --> 00:06:21,464 obesity and overweight as a whole is a 179 00:06:21,464 --> 00:06:23,944 piece that's sometimes forgotten about as well. So 180 00:06:23,944 --> 00:06:26,925 that's another, strategy that can be employed too. 181 00:06:26,985 --> 00:06:29,705 Yeah. It's fascinating. And it brings to mind 182 00:06:29,705 --> 00:06:32,264 how I'm noticing a trend there, you know, 183 00:06:32,264 --> 00:06:34,819 beyond weight loss, but even fitness apps, I 184 00:06:34,819 --> 00:06:36,199 know they used to be strictly 185 00:06:36,740 --> 00:06:38,579 workout based. And here's your workout for the 186 00:06:38,579 --> 00:06:40,099 day or the week. But now there are 187 00:06:40,099 --> 00:06:42,759 these community elements. I've noticed so many providers 188 00:06:42,979 --> 00:06:45,220 adding on, and I it sounds like there's 189 00:06:45,220 --> 00:06:47,300 certainly something behind that Yeah. Having a support 190 00:06:47,300 --> 00:06:49,395 system. Yeah. And it's, you know, it's not 191 00:06:49,395 --> 00:06:51,475 the right thing for every individual, but it's, 192 00:06:51,475 --> 00:06:53,154 you know, some people really wanna keep their 193 00:06:53,154 --> 00:06:53,654 anonymity. 194 00:06:53,955 --> 00:06:56,754 Mhmm. But others really do wanna be able 195 00:06:56,754 --> 00:06:59,235 to share those successes or, you know, you 196 00:06:59,235 --> 00:07:01,555 find someone that, like I was just talking 197 00:07:01,555 --> 00:07:02,915 with a coworker at our booth. We were 198 00:07:02,915 --> 00:07:03,415 comparing, 199 00:07:03,795 --> 00:07:06,590 on our Oura ring stats, like our, cardiovascular 200 00:07:06,970 --> 00:07:09,449 age. And she's like, I'm at 6.5. I 201 00:07:09,449 --> 00:07:10,970 really wanna be at nine. And I'm like, 202 00:07:10,970 --> 00:07:12,330 oh, well, I'm at nine. She's like, well, 203 00:07:12,330 --> 00:07:14,569 now I'm chasing you. So it's like this, 204 00:07:14,569 --> 00:07:16,970 you know, fun competitiveness of like, oh, I 205 00:07:16,970 --> 00:07:19,210 I see it's attainable. So I wanna I 206 00:07:19,210 --> 00:07:21,225 want to be like that, And I wanna 207 00:07:21,225 --> 00:07:22,824 learn from them as far as how they 208 00:07:22,824 --> 00:07:25,545 got there, and just develop those connections with 209 00:07:25,545 --> 00:07:28,105 people. Yeah. Fascinating. Oh, I feel like I 210 00:07:28,105 --> 00:07:29,884 could talk about this with you all day. 211 00:07:29,944 --> 00:07:31,625 I know we have limited time, so I 212 00:07:31,625 --> 00:07:33,225 do wanna make sure we kind of touch 213 00:07:33,225 --> 00:07:36,029 on where GLP ones are headed and the 214 00:07:36,029 --> 00:07:38,350 future landscape for those. We know that the 215 00:07:38,350 --> 00:07:40,830 usage of this treatment is expanding past diabetes 216 00:07:40,830 --> 00:07:43,310 and weight loss into other therapeutic areas too. 217 00:07:43,310 --> 00:07:43,810 So 218 00:07:44,110 --> 00:07:45,550 from your view, what do you think payers 219 00:07:45,550 --> 00:07:47,714 should really be anticipating right now with cost 220 00:07:47,875 --> 00:07:49,574 coverage and also innovation? 221 00:07:50,274 --> 00:07:51,794 Is there one action they could take now 222 00:07:51,794 --> 00:07:53,735 to better prepare? Yeah. There's definitely 223 00:07:54,194 --> 00:07:55,095 many more, 224 00:07:55,475 --> 00:07:57,954 conditions that are now, you know, covered to 225 00:07:57,954 --> 00:08:01,314 use GLP-one medications, like obstructive sleep apnea, fatty 226 00:08:01,314 --> 00:08:02,134 liver disease. 227 00:08:02,959 --> 00:08:04,959 I think I think the challenge is now 228 00:08:04,959 --> 00:08:06,720 you continue to open the door for these 229 00:08:06,720 --> 00:08:09,279 other diagnoses to use these medications, which will 230 00:08:09,279 --> 00:08:10,500 absolutely help. 231 00:08:10,959 --> 00:08:13,360 But, again, we're still not addressing the main 232 00:08:13,360 --> 00:08:15,600 problem of we're just giving someone a medication, 233 00:08:15,600 --> 00:08:17,935 and we're not supporting the components that need 234 00:08:17,935 --> 00:08:19,154 to come with that medication. 235 00:08:19,535 --> 00:08:21,694 You wouldn't just hand insulin off to a 236 00:08:21,694 --> 00:08:24,675 diabetic without teaching them how to use insulin, 237 00:08:24,974 --> 00:08:27,055 the proper nutrition that goes with that, what 238 00:08:27,055 --> 00:08:29,189 to do if you have side effects. It's 239 00:08:29,189 --> 00:08:33,190 the same way with GLP-one medications. Mhmm. Maybe 240 00:08:33,190 --> 00:08:35,990 not necessarily as severe in some cases, but 241 00:08:35,990 --> 00:08:37,589 you have to be able to frame it 242 00:08:37,589 --> 00:08:40,009 with, there needs to be some very thorough 243 00:08:40,629 --> 00:08:42,789 education and prescription that goes along with that 244 00:08:42,789 --> 00:08:45,254 medication to be able to make that successful. 245 00:08:46,514 --> 00:08:48,034 Yeah. And I think when we look at 246 00:08:48,034 --> 00:08:50,034 the pipeline coming down the line, we know 247 00:08:50,034 --> 00:08:51,875 that there's some oral medications that are in, 248 00:08:51,875 --> 00:08:53,794 like, phase three testing that will probably come 249 00:08:53,794 --> 00:08:56,134 to market late this year, early next year. 250 00:08:56,434 --> 00:08:58,514 I think our biggest hope, honestly, with those 251 00:08:58,514 --> 00:09:00,730 is that will help reduce the price, which 252 00:09:00,730 --> 00:09:03,129 can reduce access to the medications as well, 253 00:09:03,129 --> 00:09:04,750 which then allows us to 254 00:09:05,610 --> 00:09:09,129 utilize these medications for individuals that maybe aren't 255 00:09:09,129 --> 00:09:11,529 on a health plan that covers them. Maybe, 256 00:09:11,529 --> 00:09:13,690 you know, from a health equity standpoint, can 257 00:09:13,690 --> 00:09:16,195 we start to utilize these medications in underserved 258 00:09:16,414 --> 00:09:16,914 populations 259 00:09:17,615 --> 00:09:20,014 that don't have the opportunity today because of 260 00:09:20,014 --> 00:09:21,475 the cost and it's so prohibitive? 261 00:09:22,495 --> 00:09:24,835 So there's there's a lot. And, you know, 262 00:09:24,894 --> 00:09:26,995 they're going to continue to have 263 00:09:27,419 --> 00:09:27,740 more, 264 00:09:28,460 --> 00:09:30,620 pharmaceuticals that will come to market, and they'll 265 00:09:30,620 --> 00:09:32,860 probably continue to be more conditions that will 266 00:09:32,860 --> 00:09:34,080 be covered by the medications. 267 00:09:35,100 --> 00:09:36,940 That one, though, one other point I think 268 00:09:36,940 --> 00:09:39,179 to make on that that's interesting, because this 269 00:09:39,179 --> 00:09:41,019 came up in our session as far as 270 00:09:41,019 --> 00:09:42,165 when when you think about some of the 271 00:09:42,165 --> 00:09:44,245 other conditions that will be covered for GLP 272 00:09:44,245 --> 00:09:44,745 ones, 273 00:09:45,445 --> 00:09:47,524 they can be affected if someone loses weight. 274 00:09:47,524 --> 00:09:48,825 So if you lose weight, 275 00:09:49,365 --> 00:09:51,524 does your sleep apnea improve? If you lose 276 00:09:51,524 --> 00:09:53,285 weight, does your fatty liver improve? You know, 277 00:09:53,285 --> 00:09:55,125 like, so all of these additional conditions that 278 00:09:55,125 --> 00:09:56,904 are so intertwined with obesity. 279 00:09:57,419 --> 00:09:59,100 So if we can solve for one, can 280 00:09:59,100 --> 00:10:00,240 we solve for all? 281 00:10:00,620 --> 00:10:02,539 And is it worth putting a lot of 282 00:10:02,539 --> 00:10:05,360 resource into solving the obesity issue 283 00:10:05,820 --> 00:10:08,059 before trying to solve everything else that can 284 00:10:08,059 --> 00:10:09,200 cascade from that? 285 00:10:09,745 --> 00:10:13,205 Fascinating. It's it's complex when you think about, 286 00:10:13,504 --> 00:10:15,745 to your point, this cascade effect that we 287 00:10:15,745 --> 00:10:18,144 can envision with, you know, as these GLP 288 00:10:18,144 --> 00:10:19,745 ones are in the market as time goes 289 00:10:19,745 --> 00:10:22,304 on and coverage expands. Mhmm. But what I'm 290 00:10:22,304 --> 00:10:24,580 hearing in your response, Jennifer, is that the 291 00:10:24,580 --> 00:10:26,259 best thing for organizations to do right now 292 00:10:26,259 --> 00:10:28,259 is to be thinking about the future, not 293 00:10:28,259 --> 00:10:29,700 just to be living in this here and 294 00:10:29,700 --> 00:10:32,179 now. Can we give GLP ones? What's it 295 00:10:32,179 --> 00:10:33,659 going to cost? It's more than that. It's 296 00:10:33,779 --> 00:10:36,524 Yeah. Building a plan and intention behind the 297 00:10:36,524 --> 00:10:38,684 intervention. Yeah. And and, you know, right now, 298 00:10:38,684 --> 00:10:40,365 it's GLP ones. And who's to say that 299 00:10:40,365 --> 00:10:42,284 there's not some other new peptide that comes 300 00:10:42,284 --> 00:10:44,524 to market in the next three years that's 301 00:10:44,524 --> 00:10:47,404 even more expensive or, you know, has different 302 00:10:47,404 --> 00:10:49,664 pathways as far as within the body? So 303 00:10:50,169 --> 00:10:52,970 to your point, yes. Developing a strategy that 304 00:10:52,970 --> 00:10:55,129 will take you three to five years ahead 305 00:10:55,129 --> 00:10:57,049 of time to be able to know what's 306 00:10:57,049 --> 00:10:58,590 coming to market and address 307 00:10:59,049 --> 00:11:01,850 future medications and in future treatments as well. 308 00:11:01,850 --> 00:11:03,790 Yeah. We've definitely been kind of playing, 309 00:11:04,495 --> 00:11:04,995 reactive, 310 00:11:05,774 --> 00:11:07,054 with a lot of this as far as, 311 00:11:07,054 --> 00:11:08,815 oh, it's on the market now. How are 312 00:11:08,815 --> 00:11:09,934 we gonna cover it? What are we gonna 313 00:11:09,934 --> 00:11:11,214 do? And it's like, well, we should have 314 00:11:11,214 --> 00:11:13,054 thought about this, you know, three to five 315 00:11:13,054 --> 00:11:15,695 years ago before the before the Wegovis and 316 00:11:15,695 --> 00:11:18,710 the Zebbounds came to market. Yeah. Innovation, the 317 00:11:18,710 --> 00:11:20,629 piece of it's moving quickly and we have 318 00:11:20,629 --> 00:11:22,870 to keep up. Yeah. But, Jennifer, I so 319 00:11:22,870 --> 00:11:24,790 appreciate all the insights you've given us today 320 00:11:24,790 --> 00:11:26,410 in the short amount of time together. 321 00:11:27,029 --> 00:11:28,549 Anything that we didn't hit on that you 322 00:11:28,549 --> 00:11:29,990 think would be helpful for our audience to 323 00:11:29,990 --> 00:11:31,129 know before we close? 324 00:11:31,754 --> 00:11:33,835 I think just some statistics, I think, just 325 00:11:33,835 --> 00:11:36,254 to keep in mind. I shared these earlier 326 00:11:36,394 --> 00:11:38,975 because I think it is just fascinating. When 327 00:11:39,035 --> 00:11:41,915 we think about GLP-one medications, the first one 328 00:11:41,915 --> 00:11:44,495 actually came to market in 02/2005. 329 00:11:45,269 --> 00:11:47,669 So it's a lot different as far as 330 00:11:47,669 --> 00:11:50,070 with the effectiveness and and side effects and 331 00:11:50,070 --> 00:11:51,589 outcomes that we see with the ones that 332 00:11:51,589 --> 00:11:53,669 are in market now. But we've had the 333 00:11:53,669 --> 00:11:56,629 opportunity to really capitalize on these medications and 334 00:11:56,629 --> 00:11:59,289 hopefully bend the curve from an obesity standpoint, 335 00:11:59,589 --> 00:12:00,490 and we haven't. 336 00:12:00,884 --> 00:12:02,884 So, you know, our obesity rate is still 337 00:12:02,884 --> 00:12:05,125 above forty two percent. We combine that with 338 00:12:05,125 --> 00:12:07,845 overweight, it's above seventy percent. That's projected, you 339 00:12:07,845 --> 00:12:09,845 know, obesity rates are projected to be above 340 00:12:09,845 --> 00:12:11,684 fifty percent in the next five years or 341 00:12:11,684 --> 00:12:12,184 so. 342 00:12:12,565 --> 00:12:13,304 We had, 343 00:12:13,610 --> 00:12:16,250 ten years ago, 41 states that had an 344 00:12:16,250 --> 00:12:18,190 obesity rate below thirty percent. 345 00:12:18,970 --> 00:12:21,710 Today, it's eight. So in ten years, 346 00:12:22,090 --> 00:12:22,750 we have 347 00:12:23,129 --> 00:12:24,190 achieved this 348 00:12:24,490 --> 00:12:26,889 huge amount of people that have now become 349 00:12:26,889 --> 00:12:27,375 obese. 350 00:12:28,414 --> 00:12:30,254 And when we think about, like, we've had 351 00:12:30,254 --> 00:12:31,235 these great medications, 352 00:12:32,014 --> 00:12:33,855 but they're not changing. It's not bending the 353 00:12:33,855 --> 00:12:35,934 curve at all. We have to do something 354 00:12:35,934 --> 00:12:37,475 different in order to truly 355 00:12:38,254 --> 00:12:40,559 get the impact from the medication, but also 356 00:12:40,559 --> 00:12:42,639 get people healthier. Like, we're spending more and 357 00:12:42,639 --> 00:12:44,799 more from a payer perspective, from an employer 358 00:12:44,799 --> 00:12:46,340 perspective, and a member perspective. 359 00:12:46,799 --> 00:12:48,480 We have to be able to think about 360 00:12:48,480 --> 00:12:51,299 this differently to truly have an impact. Yeah. 361 00:12:51,440 --> 00:12:53,595 Oh, you're leaving a lot for our listeners 362 00:12:53,595 --> 00:12:55,934 to think about, Jennifer. I I so appreciated 363 00:12:55,995 --> 00:12:58,154 our conversation today. Thank you so much for 364 00:12:58,154 --> 00:13:00,154 making time for Becker's. Yeah. Thanks so much. 365 00:13:00,154 --> 00:13:01,914 It's a pleasure. Yeah. And we'd also like 366 00:13:01,914 --> 00:13:04,174 to thank Noom for sponsoring today's podcast. 367 00:13:04,586 --> 00:13:06,426 And listeners, be sure to tune into more 368 00:13:06,426 --> 00:13:08,986 podcasts at Becker's Healthcare by visiting the podcast 369 00:13:08,986 --> 00:13:11,646 page at beckershospitalreview.com.